Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-5 of 5
Keywords: endothelium-derived hyperpolarizing factor
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
AT 1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans
Available to PurchaseJeremy Bellien, Michele Iacob, Helene Eltchaninoff, Ryad Bourkaib, Christian Thuillez, Robinson Joannides
Journal:
Clinical Science
Clin Sci (Lond) (2007) 112 (7): 393–401.
Published: 01 March 2007
...- L -arginine)], after a single oral administration of telmisartan (80 mg) or placebo, using a randomized double-blind cross-over design. In six volunteers, we also assessed the roles of prostacyclin and EDHF (endothelium-derived hyperpolarizing factor) during radial FMD after AT 1 receptor blockade...
Articles
To b'EET or not to b'EET? That is the question!
Available to Purchase
Journal:
Clinical Science
Clin Sci (Lond) (2003) 105 (4): 399–401.
Published: 01 October 2003
...Amrita AHLUWALIA Since the discovery of endothelium-derived hyperpolarizing factor (EDHF), several different candidates and pathways have been proposed as mediators of endothelium-dependent hyperpolarization of vascular smooth muscle. In particular, there has been considerable support for a role...
Articles
Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole
Available to PurchaseJens PASSAUER, Eckhart BÜSSEMAKER, Grit LÄSSIG, Frank PISTROSCH, Joachim FAULER, Peter GROSS, Ingrid FLEMING
Journal:
Clinical Science
Clin Sci (Lond) (2003) 105 (4): 513–518.
Published: 01 October 2003
... -independent vasorelaxation in the human forearm. However, determining the contribution of this enzyme to regulation of blood flow in pathological conditions associated with endothelial dysfunction requires further studies. bradykinin cytochrome P450 endothelium-derived hyperpolarizing factor forearm...
Articles
Effects of the protein kinase Cβ inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes
Available to Purchase
Journal:
Clinical Science
Clin Sci (Lond) (2002) 103 (3): 311–321.
Published: 15 August 2002
... and endothelium-derived hyperpolarizing factor. When the former was abolished during nitric oxide synthase inhibition, an 80% diabetic deficit in the remaining relaxation was noted. LY333531 treatment attenuated the development of these defects by 64% and 53% respectively. Thus protein kinase Cβ contributes...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (1995) 88 (6): 611–622.
Published: 01 June 1995
... not to do so in significant amounts. Thirty per cent of the relaxation induced by acetylcholine in human small arteries is mediated by release of endothelium-derived nitric oxide, whereas more than 60% is the result of release of another agent, perhaps the putative endothelium-derived hyperpolarizing factor...